Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Caribou Biosciences Announces FDA Clearance Of IND Application For CB-012, An Allogeneic Anti-CLL-1 CAR-T Cell Therapy For The Treatment Of Relapsed Or Refractory Acute Myeloid Leukemia

Author: Bill Haddad | October 18, 2023 08:00am

Posted In: CRBU

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist